immunoSEQ Blog

Adaptive Customer Publish Latest Results in Blood (online)

A couple of weeks ago, a team of researchers from Emory University, Fred Hutchinson Cancer Research Center, Adaptive Biotechnologies, University of Minnesota, and Seattle Children’s Research Institute published results from a study in which they used the immunoSEQ assay to study the effects of CMV reactivations in post-transplant CD8 reconstitution and exhaustively evaluate the underlying TCRβ immune repertoire. … Read More→

Categorized in: Announcements |

Adaptive Customers Publish Latest Results in Blood (online)

A couple of weeks ago, a team of researchers from Boston Children’s Hospital, Harvard Medical School, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, San Raffaele Scientific Institute, and Hospital for Sick Children published results from a study in which they used the immunoSEQ assay to study the immune responses of humanized mice lacking murine MHCII… Read More→

Categorized in: Announcements |

Adaptive Biotechnologies and Collaborators to Present 4 Studies Demonstrating Clinical Relevance of Immunosequencing in the Treatment of Solid Tumors at the 2015 American Association for Cancer Research Annual Meeting

Adaptive Biotechnologies and Collaborators to Present 4 Studies Demonstrating Clinical Relevance of Immunosequencing in the Treatment of Solid Tumors at the 2015 American Association for Cancer Research Annual Meeting Seattle, WA – Adaptive Biotechnologies, the company pioneering Next Generation Sequencing (NGS) applications for cancer immunology, and its collaborators will present data demonstrating how profiling a… Read More→

Categorized in: Announcements |

Adaptive Customers Publish Latest Results in Immunology

A couple of months ago, a team of researchers from Oregon Health & Science University, KwaZulu-Natal Research Institute, Massachusetts General Hospital, Johns Hopkins School of Medicine, and Ragon Institute published results from a study in which they used the immunoSEQ assay to define a phenotypic marker panel to identify bacterial-reactive MR1-restrictive MAIT cells and broadly characterize… Read More→

Categorized in: Announcements |

Adaptive announces Multiple Myeloma Research Foundation and University of Torino 5 year collaboration

  Multiple Myeloma Research Foundation, University of Torino and Adaptive Biotechnologies Work to Speed Novel Minimal Residual Disease Monitoring Technologies to Patients   NORWALK, Conn. & SEATTLE – April 14, 2015 – The Multiple Myeloma Research Foundation (MMRF), in collaboration with the University of Torino (UofT) and Adaptive Biotechnologies, today announced a collaboration to perform sequencing-based… Read More→

Categorized in: Announcements |

Updates to the immunoSEQ Analyzer

This week, our immunoSEQ Analyzer website was updated with some new feature and user experience improvements. This release contains features that are visible to customers as well as tool and infrastructure work. Two of the more popular customer-facing features are summarized below. This release also includes numerous interface improvement throughout the Analyzer. R-Connector makes it easy… Read More→

Categorized in: Announcements, Software Tips |

Adaptive Customers Publish Latest Results in blood

About a month ago, a team of researchers from San Raffaele Scientific Institute, University of Modena and Reggio Emilia and University Vita-Salute San Raffaele published results from a study in which they used the immunoSEQ assay to track memory stem T cell (TSCM) dynamics in patients undergoing haploidentical hematopoietic stem cell transplantation (HSCT) and determine… Read More→

Categorized in: Announcements |

Adaptive Customers Publish Latest Results in Nature Letters

A couple weeks ago, a team of researchers from University of Pennsylvania and University of Miami published results from a study in which they used the immunoSEQ assay to investigate the mechanism of action (MOA) of checkpoint blockades and radiation therapy. The overall conclusion was that PDL-1 expression by tumor cells is responsible for mediating resistance to… Read More→

Categorized in: Announcements |

Adaptive Customers Publish Latest Results in Journal of Immunology

Screen Shot 2015-03-24 at 4.11.02 PM

A couple weeks ago, a team of researchers from Icahn School of Medicine at Mount Sinai published results from a study in which they used the immunoSEQ assay to examine the effect of two different classes of activating agents (Toll-like receptor (TLR) stimulation versus CD40L/IL21) on B cell memory differentiation and function. The overall conclusion was the… Read More→

Categorized in: Announcements |

Immunology, Seattle, and Biotech Growth from a Rep’s Perspective

From our Southwest Rep Kyle O’Connor… Living in San Diego, I find that I focus on the local business news, often hearing about the strong local biotech or computer technology economy, and not regularly see how other cities and regions are faring during this slow time of economic recovery. It seems that several regions in… Read More→